EMvision Medical Devices Ltd. (AU:EMV)
ASX:EMV
Want to see AU:EMV full AI Analyst Report?
EMV Stock Chart & Stats
AU$1.77
-AU$0.06(-3.19%)
At close: 4:00 PM EST
AU$1.77
-AU$0.06(-3.19%)
Day’s Range― - ―
52-Week RangeAU$1.48 - AU$2.43
Previous CloseN/A
Volume36.00K
Average Volume (3M)120.98K
Market Cap
AU$166.82M
Enterprise ValueAU$152.84M
Total Cash (Recent Filing)AU$17.56M
Total Debt (Recent Filing)AU$4.02M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding92,938,610
10 Day Avg. Volume127,185
30 Day Avg. Volume120,982
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)16.01
Price to Sales (P/S)29.42
P/FCF Ratio-18.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$3.15Price Target Upside77.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.1
Revenue Forecast (FY)AU$6.00M
Bulls Say, Bears Say
Bulls Say
Addressable Market & Use CaseEMvision's product focus targets a durable clinical need: rapid, point-of-care brain imaging for stroke and TBI. This use case aligns with long-term structural demand from emergency medicine and hospital workflows, supporting sustained adoption if regulatory and reimbursement paths progress.
Moderate LeverageA debt-to-equity ratio of 0.38 indicates conservative leverage relative to high-burn medtech peers, giving management flexibility to fund near-term development and operations without excessive interest burden, supporting resilience across a 2–6 month horizon.
High Gross Margin PotentialA reported 100% gross margin suggests the device economics can be highly scalable once revenue ramps. If management controls operating spend and execution improves, gross-margin strength can support sustainable profitability over time as sales grow.
Bears Say
Declining RevenueA steep revenue decline erodes scale needed to absorb fixed R&D and commercialization costs. Persistently falling sales make it harder to validate the business model, jeopardize investment in clinical trials, and increase reliance on external funding over the medium term.
Negative Operating Cash FlowNegative operating and free cash flow indicate ongoing cash burn and limited internal funding capacity. This structural cash shortfall can force dilutive financing or constrain commercialization investments, raising execution risk over the next several quarters.
Persistent Losses And Weak ProfitabilitySustained negative EBIT and net margins and poor ROE show the company is not yet converting R&D and sales efforts into profits. Long-term viability depends on reversing losses, making current profitability trends a material structural headwind for growth and partner confidence.
EMvision Medical Devices Ltd. News
EMV FAQ
What was EMvision Medical Devices Ltd.’s price range in the past 12 months?
EMvision Medical Devices Ltd. lowest share price was AU$1.48 and its highest was AU$2.43 in the past 12 months.
What is EMvision Medical Devices Ltd.’s market cap?
EMvision Medical Devices Ltd.’s market cap is AU$166.82M.
When is EMvision Medical Devices Ltd.’s upcoming earnings report date?
EMvision Medical Devices Ltd.’s upcoming earnings report date is Sep 01, 2026 which is in 130 days.
How were EMvision Medical Devices Ltd.’s earnings last quarter?
EMvision Medical Devices Ltd. released its earnings results on Feb 22, 2026. The company reported -AU$0.044 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.044.
Is EMvision Medical Devices Ltd. overvalued?
According to Wall Street analysts EMvision Medical Devices Ltd.’s price is currently Undervalued.
Does EMvision Medical Devices Ltd. pay dividends?
EMvision Medical Devices Ltd. does not currently pay dividends.
What is EMvision Medical Devices Ltd.’s EPS estimate?
EMvision Medical Devices Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EMvision Medical Devices Ltd. have?
EMvision Medical Devices Ltd. has 92,938,610 shares outstanding.
What happened to EMvision Medical Devices Ltd.’s price movement after its last earnings report?
EMvision Medical Devices Ltd. reported an EPS of -AU$0.044 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of EMvision Medical Devices Ltd.?
Currently, no hedge funds are holding shares in AU:EMV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EMvision Medical Devices Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$3.15 (77.97% Upside)
AU$3.15 (77.97% Upside)
Blogger Sentiment
Bullish
AU:EMV Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.44%
12-Months-Change
Fundamentals
Return on Equity
-70.29%
Trailing 12-Months
Asset Growth
25.56%
Trailing 12-Months
Company Description
EMvision Medical Devices Ltd.
EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis, monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
EMV Stock 12 Month Forecast
Average Price Target
AU$3.15
▲(77.97% Upside)
Technical Analysis
Compumedics Limited
―
Impedimed Limited
―
Cyclopharm Limited
―
Aroa Biosurgery Ltd
―
4DMedical Ltd
―